Form 4 Filing for ADIAL PHARMACEUTICALS, INC. - Wendy B. Young

This filing details a transaction by Wendy B. Young, a director at ADIAL PHARMACEUTICALS, INC. (ADIL), on June 12, 2026. Ms. Young acquired 36,378 pre-funded warrants for common stock at a price of $2.7489 per share. These warrants, issued under a pre-funded warrant agreement dated June 12, 2026, have no expiration date. However, their exercise is subject to a beneficial ownership limitation of 4.99% of the issuer's outstanding common stock. The transaction was reported on Form 4, with Ms. Young acquiring these securities indirectly. The post-transaction shares owned amount to 36,378. The filing also notes that the exercise price for these warrants is $0.001.